California Dentist Ebook Continuing Education

Course 7: Medication-Related Damage to Soft and Hard Dental Structures 2 CE Hours Release Date: July 10, 2023 Expiration Date: July 10, 2026 Faculty

Mark Donaldson, BSP, RPH, PharmD, ACPR, FASHP, FACHE , received his baccalaureate degree from the University of British Columbia and his doctorate in clinical pharmacy from the University of Washington. He has further completed a residency at Canada’s largest tertiary care facility, Vancouver General Hospital, and is the current AVP of Pharmacy Consulting Services at Vizient. Dr. Donaldson is a clinical professor in the Department of Pharmacy at the University of Montana in Missoula, and clinical associate professor in the School of Dentistry at the Oregon Health & Science University in Portland. He has a special interest in dental pharmacology and has lectured internationally to both dental and medical practitioners. Dr. Donaldson has a number of published works in the peer-reviewed literature and has co-authored textbook chapters. He spent three years in Japan focusing on cross-cultural communication and internationalization. He currently serves on the Editorial

Board for The Journal of the American Dental Association (JADA), is board-certified in healthcare management, and is the past-president and past-Regent of the American College of Healthcare Executives’ Montana Chapter. In 2016 he was recognized by the Academy of General Dentistry as the recipient of the Dr. Thaddeus V. Weclew Award. This award is conferred upon an individual who has made outstanding contributions to the art and science of dentistry and/or enhanced the principles and ideals of the Academy. In 2019 he was awarded the, “Special Friend of Canadian Dentistry Award,” by the Canadian Dental Association (CDA) in Ottawa. This international award is given to an individual outside of the dental profession in appreciation for exemplary support or service to Canadian dentistry and/ or to the profession as a whole. Mark Donaldson has no significant financial or other conflicts of interest pertaining to this course. ● Provide required personal information and payment information. ● Complete the mandatory Course Evaluation. ● Print your Certificate of Completion.

How to receive credit ● Read the entire course online or in print.

● Answer the final examination questions at the end of the course (a passing grade of 75% is required). Test questions link content to learning objectives as a method to enhance individualized learning and material retention.

Disclosures Resolution of conflict of interest

Sponsorship/commercial support and non-endorsement It is the policy of Colibri Healthcare, LLC not to accept commercial support. Furthermore, commercial interests are prohibited from distributing or providing access to this activity to learners.

Colibri Healthcare, LLC implemented mechanisms prior to the planning and implementation of the continuing education activity, to identify and resolve conflicts of interest for all individuals in a position to control content of the course activity. Disclaimer The information provided in this activity is for continuing education purposes only and is not meant to substitute for the independent medical judgment of a healthcare provider

relative to diagnostic and treatment options of a specific patient’s medical condition.

©2024: All Rights Reserved. Materials may not be reproduced without the expressed written permission or consent of Colibri Healthcare, LLC. The materials presented in this course are meant to provide the consumer with general information on the topics covered. The information provided was prepared by professionals with practical knowledge of the areas covered. It is not meant to provide medical, legal, or professional advice. Colibri Healthcare, LLC recommends that you consult a medical, legal, or professional services expert licensed in your state. Colibri Healthcare, LLC has made all reasonable efforts to ensure that all content provided in this course is accurate and up to date at the time of printing, but does not represent or warrant that it will apply to your situation nor circumstances and assumes no liability from reliance on these materials. Quotes are collected from customer feedback surveys. The models are intended to be representative and not actual customers. AGD Subject Code - 741. This course meets the Dental Board of California's requirements for 2 units of continuing education. INTRODUCTION Learning outcomes

Š Describe drug-related effects on the oral soft tissues, including gingival enlargement, mucosal disorders, white lesions, and salivary gland disorders. Š Recognize drug-related changes to salivary glands and how to manage these effects.

After completing this course, the learner will be able to: Š Identify common chemical- and medication-related damage to oral hard tissues and their dental management. Š Identify common damage to oral soft tissues resulting in color changes to the oral mucosa.

EliteLearning.com/Dental

Page 125

Powered by